Deferasirox | Aplastic Anemia and MDS International Foundation

Deferasirox

An iron chelator, this drug is used to remove excess iron from the body.
Brand name: 
Exjade, Jadenu
Bone Marrow Disease(s): 
aplastic anemia
myelodysplastic syndromes (MDS)
paroxysmal nocturnal hemoglobinuria (PNH)

It comes in a tablet form which is dissolved in juice or water and taken by mouth. Iron build-up can occur in patients who get a lot of red blood cell transfusions. Deferasirox binds with the iron in the body and is removed by the kidneys. Bone marrow failure disease patients are at risk for developing iron overload if they have had more than 20 units of packed red blood cells.

Related Clinical Trials

AAMDSIF does not recommend, endorse, or make any representation about the efficacy, appropriateness or suitability of any drug, treatment or therapy listed on this website. Some therapies listed on our site are considered experimental for the treatment of bone marrow failure diseases. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding any therapy, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.